Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern Cooperative Oncology Group E2303
Amanda Psyrri, Ju Whei Lee, Eirini Pectasides, Maria Vassilakopoulou, Efstratios K. Kosmidis, Barbara A. Burtness, David L. Rimm, Harold J. Wanebo, Arlene A. Forastiere
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern Cooperative Oncology Group E2303'. Together they form a unique fingerprint.